FAS and idiopathic pulmonary fibrosis: Treatment of IPF fibroblasts with the HDAC inhibitor TSA, but not the DNA methylation inhibitor 5-aza-dC, resulted in increased Fas mRNA (Figure 7a) and protein expression (Figure 7b).